Unprecedented advances have been made in cancer treatment with the use of immune
checkpoint blockade (ICB). However, responses are limited to a subset of patients, and …

Immune checkpoint blockade (ICB) has rapidly transformed the treatment paradigm for
various cancer types. Multiple single or combinations of ICB treatments have been approved …

Targeted immune checkpoint blockade augments anti-tumor immunity and induces durable
responses in patients with melanoma and other solid tumors. It also induces specific …

The emergence of immune checkpoint blockade therapies over the last decade has
transformed cancer treatment in a wide range of tumor types. Unprecedented and durable …

Unprecedented advances have been made in the treatment of cancer through the use of
immune checkpoint blockade, with approval of several checkpoint blockade regimens …

Immune checkpoint blockade therapy (ICBT), which blocks negative immune-activating
signals and maintains the antitumor response, has elicited a remarkable clinical response in …

Immune checkpoint therapy (ICT) has dramatically altered clinical outcomes for cancer
patients and conferred durable clinical benefits, including cure in a subset of patients …

Immune checkpoint therapy (ICT) can provide durable clinical responses and improve
overall survival. However, only subsets of patients with specific tumor types respond to ICT …

Immune checkpoint inhibitors (ICIs) have made an indelible mark in the field of cancer
immunotherapy. Starting with the approval of anti-cytotoxic T lymphocyte-associated protein …

Immunotherapy is currently transforming cancer treatment. Notably, immune checkpoint
blockers (ICB) have shown unprecedented therapeutic successes in numerous tumor types …